MODULATING COMPOUNDS OF KCHIP2 AND ITS USE FOR THE TREATMENT OF CARDIOVASCULAR PATHOLOGIES
CSIC and UAM have developed compounds that positively modulate protein-protein interactions that involve KChIP2 protein.
Industrial partners from the pharmaceutical industry are being sought to collaborate through a patent licence agreement